期刊文献+

Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement 被引量:11

Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement
下载PDF
导出
摘要 Liver fibrosis is a common histological change of chronic liver injury and it is closely related with portalhypertension which is hemodynamic complication of chronic liver disease. Currently, liver fibrosis has been known as a reversible dynamic process in previous literatures. Although liver biopsy is a gold standard for assessing the stage of liver fibrosis, it may not completely represent the stage of liver fibrosis because of sampling error or semi-quantative measurement. Recent evidences suggested that histologic, clinical, hemodynamic, and biologic features are closely associated in patients with chronic liver disease. Hepatic venous pressure gradient(HVPG) measurement has been known as a modality to evaluate the portal pressure. The HVPG measurement has been used clinically for fibrosis diagnosis, risk stratification, preoperative screening for liver resection, monitoring the efficacy of medical treatments, and assessing the prognosis of liver fibrosis. Therefore, the HVPG measurement can be used to monitor areas the chronic liver disease but also other important areas of chronic liver disease. Liver fibrosis is a common histological change ofchronic liver injury and it is closely related with portalhypertension which is hemodynamic complication ofchronic liver disease. Currently, liver fibrosis has beenknown as a reversible dynamic process in previousliteratures. Although liver biopsy is a gold standardfor assessing the stage of liver fibrosis, it may notcompletely represent the stage of liver fibrosis becauseof sampling error or semi-quantative measurement.Recent evidences suggested that histologic, clinical,hemodynamic, and biologic features are closelyassociated in patients with chronic liver disease. Hepaticvenous pressure gradient (HVPG) measurement has beenknown as a modality to evaluate the portal pressure.The HVPG measurement has been used clinicallyfor fibrosis diagnosis, risk stratification, preoperativescreening for liver resection, monitoring the efficacy ofmedical treatments, and assessing the prognosis of liverfibrosis. Therefore, the HVPG measurement can be usedto monitor areas the chronic liver disease but also otherimportant areas of chronic liver disease.
出处 《World Journal of Hepatology》 CAS 2015年第3期607-615,共9页 世界肝病学杂志(英文版)(电子版)
基金 Supported by A grant from the Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education,Science and Technology,No.NRF-2010-0021482 Cooperative Research Program for Agriculture Science and Technology Development Rural Development Administration,South Korea,No.PJ009859
关键词 FIBROSIS LIVER VENOUS pressure Fibrosis Liver Venous pressure
  • 相关文献

参考文献94

  • 1Karsdal MA, Krarup H, Sand JM, Christensen PB, GerstoftJ, Leeming DJ, Weis N, Schaffalitzky de Muckadell OB,Krag A. Review article: the efficacy of biomarkers in chronicfibroproliferative diseases - early diagnosis and prognosis, with liverfibrosis as an exemplar. Aliment Pharmacol Ther 2014; 40: 233-249[PMID: 24909260 DOI: 10.1111/apt.12820].
  • 2Wynn TA. Common and unique mechanisms regulate fibrosis invarious fibroproliferative diseases. J Clin Invest 2007; 117: 524-529[PMID: 17332879 DOI: 10.1172/JCI31487].
  • 3Germani G, Hytiroglou P, Fotiadu A, Burroughs AK, Dhillon AP.Assessment of fibrosis and cirrhosis in liver biopsies: an update.Semin Liver Dis 2011; 31: 82-90 [PMID: 21344353 DOI: 10.1055/s-0031-1272836].
  • 4Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y,Poynard T. Biochemical markers of liver fibrosis in patients withhepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075 [PMID: 11297957 DOI: 10.1016/S0140-6736(00)04258-6].
  • 5Brenner DA. Reversibility of liver fibrosis. Gastroenterol Hepatol(N Y) 2013; 9: 737-739 [PMID: 24764791].
  • 6Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and itscomplications. Gastroenterology 2008; 134: 1715-1728 [PMID:18471549 DOI: 10.1053/j.gastro.2008.03.007].
  • 7de Franchis R, Primignani M. Natural history of portalhypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-663 [PMID: 11565135].
  • 8Burroughs AK, McCormick PA. Natural history and prognosis ofvariceal bleeding. Baillieres Clin Gastroenterol 1992; 6: 437-450[PMID: 1421594].
  • 9Krook H. Estimation of portal venous pressure by occlusive hepaticvein catheterization. Scand J Clin Lab Invest 1953; 5: 285-292[PMID: 13135422].
  • 10Armonis A, Patch D, Burroughs A. Hepatic venous pressuremeasurement: an old test as a new prognostic marker in cirrhosis-Hepatology 1997; 25: 245-248 [PMID: 8985299 DOI: 10.1053/jhep.1997.v25.ajhep0250245].

同被引文献102

引证文献11

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部